How a trading company ended up making its own peptides
Lyotek started in Switzerland in 2022 with three people and a narrow idea: source research chemicals carefully and sell them to laboratories that needed them quickly. We bought from manufacturers, checked what we could, and shipped.
The checking turned out to be the whole job. A certificate would name a lot that matched nothing in the box. A second order of the same compound would behave differently from the first, and the paperwork could not tell us why. When a customer asked a plain question about a batch, too often we had no answer we could stand behind.
So in 2023 we stopped buying peptides and began making them. It took two years to bring synthesis, analysis, freeze-drying and filling into one building and one quality system, and in 2025 we released the first lot with our own name on the label.
We still think of ourselves as a small company. The people who release a lot sit a corridor away from the people who pack it, and the managing director still reads the complaints. We would like to keep it that way for as long as we can.
Matthias Reber, Elena Marti and Jonas Haefeli, founders




